PET scans help identify mechanism underlying seasonal mood changes

Sep 02, 2008

Brain scans taken at different times of year suggest that the actions of the serotonin transporter—involved in regulating the mood-altering neurotransmitter serotonin—vary by season, according to a report in the September issue of Archives of General Psychiatry. These fluctuations may potentially explain seasonal affective disorder and related mood changes.

"It is a common experience in temperate zones that individuals feel happier and more energetic on bright and sunny days and many experience a decline in mood and energy during the dark winter season," the authors write as background information in the article. This is thought to be related to variations in brain levels of serotonin, which is involved in the regulation of functions such as mating, feeding, energy balance and sleep. The serotonin transporter, a protein that binds to serotonin and clears it from the spaces between brain cells, "is a key element in regulating intensity and spread of the serotonin signal."

Nicole Praschak-Rieder, M.D., and Matthaeus Willeit, M.D., of the Centre for Addiction and Mental Health and the University of Toronto, Ontario, Canada, and colleagues studied 88 healthy individuals (average age 33) between 1999 and 2003. Participants underwent one positron emission tomography (PET) scan to assess serotonin transporter binding potential value, an index of serotonin transporter density. The higher the binding potential value, the less serotonin circulates in the brain. For the analysis, individual scans were grouped according to the season of the scan—fall and winter or spring and summer.

"Serotonin transporter binding potential values were significantly higher in all investigated brain regions in individuals investigated in the fall and winter compared with those investigated in the spring and summer," the authors write. When they matched binding potential values to meteorological data, the researchers found that higher values occurred during times when there were fewer hours of sunlight per day.

"An implication of greater serotonin transporter binding in winter is that this may facilitate extracellular serotonin loss during winter, leading to lower mood," the authors write. "Higher regional serotonin transporter binding potential values in fall and winter may explain hyposerotonergic [related to low serotonin levels] symptoms, such as lack of energy, fatigue, overeating and increased duration of sleep during the dark season."

"These findings have important implications for understanding seasonal mood change in healthy individuals, vulnerability to seasonal affective disorder and the relationship of light exposure to mood," they conclude. "This offers a possible explanation for the regular reoccurrence of depressive episodes in fall and winter in some vulnerable individuals."

Source: JAMA and Archives Journals

Explore further: Unsteady on your feet? Little touches could make all the difference

add to favorites email to friend print save as pdf

Related Stories

Tuning light to kill deep cancer tumors

22 minutes ago

An international group of scientists led by Gang Han, PhD, at the University of Massachusetts Medical School, has combined a new type of nanoparticle with an FDA-approved photodynamic therapy to effectively kill deep-set ...

A global natural gas boom alone won't slow climate change

43 minutes ago

A new analysis of global energy use, economics and the climate shows that without new climate policies, expanding the current bounty of inexpensive natural gas alone would not slow the growth of global greenhouse ...

Researchers develop world's thinnest electric generator

43 minutes ago

Researchers from Columbia Engineering and the Georgia Institute of Technology report today that they have made the first experimental observation of piezoelectricity and the piezotronic effect in an atomically ...

US Supreme Court weighs generic drug dispute

1 hour ago

(AP)—The US Supreme Court seems divided as it considers a high-stakes patent dispute between rival pharmaceutical companies over the world's best-selling multiple sclerosis treatment.

Recommended for you

Neutralising antibodies for safer organ transplants

16 hours ago

Serious complications can arise following kidney transplants. If dialysis is required within the first seven days, then the transplanted organ is said to have a Delayed Graft Function (DGF), and essentially ...

User comments : 0